Document Detail


Blocking the renin-angiotensin-aldosterone system or lowering the blood pressure: does EUROPA help?
MedLine Citation:
PMID:  14689366     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) demonstrated that the angiotensin- converting enzyme inhibitor, perindopril, compared with placebo, in patients with established coronary artery disease, reduced cardiovascular endpoints by 20% over a four-year follow-up period. Although the authors of this study claim that the risk reduction was best explained by blockade of the renin-angiotensin-aldosterone system, reference to recent meta-analyses of blood pressure (BP)-lowering trials provides compelling evidence that the benefits observed in the trial could be explained by the 5/2 mmHg BP difference between active and placebo treatments.
Authors:
Judy A Mackay
Related Documents :
6853676 - Basic and clinical reevaluation of tyramine and histamine tests for the investigation o...
731936 - Role of renin-angiotensin system in the controls of blood pressure and aldosterone in p...
20927116 - Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subj...
6625516 - Surgical treatment of primary aldosteronism.
21665496 - A comparative study of extra- and intraluminal sigmoid colonic tonometry to detect colo...
12002266 - Central hypercapnic chemoreflex modulation of renal sympathetic nerve activity in exper...
Publication Detail:
Type:  Comment; Journal Article; Review    
Journal Detail:
Title:  Journal of the renin-angiotensin-aldosterone system : JRAAS     Volume:  4     ISSN:  1470-3203     ISO Abbreviation:  J Renin Angiotensin Aldosterone Syst     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-22     Completed Date:  2004-01-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100971636     Medline TA:  J Renin Angiotensin Aldosterone Syst     Country:  England    
Other Details:
Languages:  eng     Pagination:  205-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, Hillingdon Hospital, Uxbridge, UB8 3NN, UK. judyasever@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects*
Controlled Clinical Trials as Topic
Coronary Disease / drug therapy
Heart Diseases / prevention & control
Humans
Perindopril / therapeutic use*
Renin-Angiotensin System / drug effects*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 82834-16-0/Perindopril
Comments/Corrections
Comment On:
J Renin Angiotensin Aldosterone Syst. 2000 Jun;1(2):117-8   [PMID:  11967800 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Schistosomiasis does not contribute to death or recurrence of nontyphoid Salmonella bacteremia in hu...
Next Document:  Subfornical organ lesion attenuates chronic hypotensive effects of losartan in salt-replete rats.